Clinical Trials
333
Active:324
Completed:5
Trial Phases
2 Phases
Phase 1:126
Not Applicable:3
Drug Approvals
85
NMPA:42
PHILIPPINES:34
SFDA:9
Drug Approvals
Ipratropium Bromide Solution for Inhalation
- Product Name
- 爱全乐
- Approval Number
- 国药准字HJ20150158
- Approval Date
- Sep 29, 2024
NMPA
Ipratropium Bromide Solution for Inhalation
- Product Name
- 爱全乐
- Approval Number
- 国药准字HJ20150159
- Approval Date
- Sep 29, 2024
NMPA
Ambroxol Hydrochloride Injection
- Product Name
- 沐舒坦
- Approval Number
- 国药准字HJ20150468
- Approval Date
- Jun 28, 2023
NMPA
Ambroxol Hydrochloride Injection
- Product Name
- 沐舒坦
- Approval Number
- 国药准字HJ20150469
- Approval Date
- Jun 28, 2023
NMPA
Ipratropium Bromide Inhalation Aerosol
- Product Name
- 爱全乐
- Approval Number
- 国药准字HJ20130499
- Approval Date
- Jan 4, 2023
NMPA
Ipratropium Bromide Inhalation Aerosol
- Product Name
- 爱全乐
- Approval Number
- 国药准字HJ20130498
- Approval Date
- Jan 4, 2023
NMPA
Linagliptin and Metformin Hydrochloride Tablets(Ⅱ)
- Product Name
- 欧双宁
- Approval Number
- 国药准字J20171039
- Approval Date
- May 21, 2020
NMPA
Linagliptin and Metformin Hydrochloride Tablets(Ⅱ)
- Product Name
- 欧双宁
- Approval Number
- J20171039
- Approval Date
- May 21, 2020
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
Clinical Trials
Distribution across different clinical trial phases (129 trials with phase data)• Click on a phase to view related trials
Phase 1
126 (97.7%)Not Applicable
3 (2.3%)No trials found
News
No news found